Search results for: 'Frost & Sullivan: Global and Chinese Pharmaceutical Market Research Report'

Enterprise awareness and adoption of artificial intelligence (AI) have accelerated significantly worldwide. Advances in AI technologies, combined with increased accessibility, are enabling businesses to integrate AI seamlessly into their operations. Nearly 90% of IT and business decision-makers recognize AI and machine learning as critical to achie...

This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support se...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

This research service provides a strategic overview and analysis of the automotive connected services market in China. It examines the market trends and challenges, and provides forecasts for the period 2014–2020. It offers a brief market overview and discusses market drivers and restraints. It provides a detailed market share and competitive analy...

10 Mar 2021  |  Global  |  Market Research

Intelligent Mobility 2020—Frost & Sullivan Research Survey Analysis and Results

The Survey Showcases Customer Understanding about Connectivity and New Themes in the Mobility Space

Infographics

×

The global mobility industry is undergoing a tectonic shift in terms of technological and business aspects. Telematics connectivity, new mobility, electric and autonomous technologies, digital retail, and last-mile delivery are a few important trends in the mobility ecosystem, and these hold significant potential to radically change the way global ...

Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...

This report briefs the Overview of GCC Pharmaceutical Market and the opportunities in the Gulf Cooperation Council (GCC) pharmaceuticals sector. It focuses on opportunities and challenges in the GCC pharmaceuticals sector as well as factors that drive its revenue and earnings. It further highlights the key trends, drivers, and restraints of the GC...

Cloud forms a critical part of the digital transformation efforts of enterprises worldwide. Cloud infrastructure, platforms, and applications extend the benefits of flexibility, scale, and cost to IT and business teams. Yet, year after year, we find that organizations report managing costs in the public cloud as a major challenge. Consequently, int...

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...